http://www.healio.com/hepatology/chronic-hepatitis/news/online/%7B679bf903-47c9-45a2-aa50-c72ece7dc9c3%7D/rep-2139-found-to-reduce-hbsag-in-caucasians-with-hbvhdv-coinfection?sc_trk=internalsearch
No one knows how I feel posting this ;;)))
https://twitter.com/RNAiAnalyst/status/591971222466011138
Dirk Haussecker
@RNAiAnalyst
#ILC2015 REPLICor reports dramatic reductions in HDV RNA and HBsAg. Looks like they cured HBV + HDV.
@RNAiAnalyst: #ILC2015 lots of people lining up to question REPLICor data. Unsurprisingly. It may be the world's best-kept secret. $100B value right there
That timeline seems fairly optimistic based on their progress the last two years, but if it is then great. More interesting questions would be whether they have made any progress in making the formulation in a subcutaneous injection form? That would be important in terms of worldwide marketability.
And the other is what happened with the 9th patient? If they developed antibodies similar to those in healthy levels and were unable to control the infection, did mutation in surface antigen occur? Based on reading studyforhope excellent posts on how HBV works and adaptability, this is very important question that needs to be answered thru the trials. Hopefully if someone attends the conference, they can get information on these issues.
Dear Andrey.
Thank you for your interest in our drug development. We believe it will still take 3 or 4 years before our drug reach the market.
Drug development is a long process.
Best regards.
Michel Bazinet, MD
Chairman and CEO
REPLICor Inc.
iam from Saudi Arabia .. i would travel too to Montreal ..if the cure completed and available for patients .. it is really positive progress towards the final destination of hbv cure ..